287 related articles for article (PubMed ID: 4075093)
1. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
Clarke PB; Pert A
Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093
[TBL] [Abstract][Full Text] [Related]
2. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways.
Gaudreau P; Quirion R; St-Pierre S; Chiueh CC; Pert A
Neuropeptides; 1987; 9(4):283-93. PubMed ID: 3614556
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.
Schotte A; Leysen JE
J Chem Neuroanat; 1989; 2(5):253-7. PubMed ID: 2553068
[TBL] [Abstract][Full Text] [Related]
4. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
Quirion R; Chiueh CC; Everist HD; Pert A
Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
[TBL] [Abstract][Full Text] [Related]
5. Opioid binding sites in the nigrostriatal system of the guinea pig are not located on nigral dopaminergic neurons.
Foote RW; Maurer R
Neurosci Lett; 1986 Apr; 65(3):341-5. PubMed ID: 3012421
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of chronic nicotine administration on dopaminergic receptor binding sites in rat nigrostriatal and mesolimbic regions.
Fung YK; Lau YS
Gen Pharmacol; 1991; 22(1):117-9. PubMed ID: 2050279
[TBL] [Abstract][Full Text] [Related]
7. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
Van der Kooy D; Weinreich P; Nagy JI
Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
Graham WC; Crossman AR; Woodruff GN
Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
10. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.
Cadet JL; Kujirai K; Przedborski S
Brain Res; 1991 Nov; 564(1):37-44. PubMed ID: 1663814
[TBL] [Abstract][Full Text] [Related]
11. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
[TBL] [Abstract][Full Text] [Related]
12. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
13. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
Julou L; Scatton B; Glowinski J
Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
[No Abstract] [Full Text] [Related]
15. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
[TBL] [Abstract][Full Text] [Related]
16. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain.
Patel S; Roberts J; Moorman J; Reavill C
Neuroscience; 1995 Dec; 69(4):1159-67. PubMed ID: 8848104
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
Kerkerian L; Salin P; Nieoullon A
Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
[TBL] [Abstract][Full Text] [Related]
18. Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat.
Kono T; Takada M
Brain Res; 1994 Jan; 634(1):155-8. PubMed ID: 8156386
[TBL] [Abstract][Full Text] [Related]
19. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
Yu H; Matsubayashi H; Amano T; Cai J; Sasa M
Brain Res; 2000 Jul; 872(1-2):223-6. PubMed ID: 10924698
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
Koulu M; Sjöholm B; Lappalainen J; Virtanen R
Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
